Abstract
The SARS-CoV-2 driven infectious novel coronavirus disease (COVID-19) has been declared a pandemic by virtue of its brutal impact on the world in terms of loss on human life, health, economy, and other crucial resources. With the aim to explore more about its aspects, we adopted the SEIQRD (Susceptible-Exposed-Infected-Quarantine-Recovered-Death) pandemic spread with a time delay on the heterogeneous population and geography in this work. Focusing on the spatial heterogeneity, the entire population of interest in a region is divided into small distinct geographical sub regions, which interact by means of migration networks across boundaries. Utilizing the estimations of the time delay differential equations based model, we analyzed the spread dynamics of disease in a region and its sub regions. The model based numerical outcomes are validated from real time available data for India. We computed the approximate peak infection in forward time and relative timespan when disease outspread halts. To further evaluate the influence of the delay on the long term system dynamics, the sensitivity analysis is performed on time delay. The most crucial parameter, basic reproduction number R0 and its time-dependent generalization, has been estimated at both regional and sub regional levels. The impact of the most significant lockdown measure that has been implemented in India to contain the pandemic spread has been extensively studied by considering no lockdown scenario. A suggestion based on outcomes, for a bit relaxed lockdown, followed by an extended period of strict social distancing as one of the most effective control measures to manage COVID-19 spread is provided for India.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A.K.G. acknowledges financial support from the Science and Engineering Board (SERB), Govt. of India [Grant No.: CRG/2019/004669].
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The epidemic bulletin from the World Health Organization provides us with primary data on epidemiological research. We gathered the dataset for COVID-19 in India from the Ministry of Health and Family Welfare (MoHFW), Government of India from March 16, 2020 to April 30, 2020 including the cumulative number of infected cases, the cumulative number of people in recovery and the cumulative number of deaths due to virus. Simultaneously, we collected the state wise total population data for India (projected 2019) from Unique Identification Authority of India (UIDAI), Government of India and migration data to capture the movement of population in different parts of the country from Ministry of Home Affairs, Government of India.
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
https://www.worldometers.info/coronavirus/
https://uidai.gov.in/images/state-wise-aadhaar-saturation.pdf
